A federal grand jury recently filed criminal charges against several developers for fraud involving a Vermont biotech company.
U.S. authorities said 24 defendants were charged in connection with one of the largest healthcare fraud schemes prosecuted by the federal government, involving telemedicine companies and resulting in more than $1.2 billion of losses.
Despite a decline over the past year of class action lawsuits, life science companies remain a popular target for securities fraud litigation.
Walgreens Boots Alliance Inc. will pay $269.2 million to settle two whistleblower lawsuits accusing the pharmacy chain of civil fraud for overbilling federal healthcare programs for over a decade.
Here is a look at BioSpace’s top 10 stories of 2018.
A hospital operator owned by Community Health Systems will pay more than $260 million to resolve claims that Health Management Associates defrauded government healthcare programs and paid doctors kickbacks for patient referrals, the U.S. Justice Department said.
New York state sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic.
A U.S. judge ordered former drug company exec Martin Shkreli to forfeit $7.36 million following his conviction of defrauding investors.
Notorious pharmaceutical entrepreneur Martin Shkreli was found guilty on two charges of securities fraud and one charge of conspiracy to commit conspiracy fraud.
Attorney General Loretta E. Lynch stands during the announcement of law enforcement action against the state of North Carolina in Washington, U.S., May 9, 2016. Reuters/Joshua Roberts/File Photo The U.S. Justice Department said Wednesday that federal law enforcement officials have hit a milestone in 2016 by completing the “largest takedown ever” against defendants allegedly trying […]